Last 2,980 INR
Change Today +104.05 / 3.62%
Volume 12.1K
GLXO On Other Exchanges
GLXO is not on other exchanges.
As of 6:07 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline pharmaceutic (GLXO) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/3/14 - 3,247
52 Week Low
06/26/14 - 2,352
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

glaxosmithkline pharmaceutic (GLXO) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline pharmaceutic (GLXO) Details

GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, CNS, and oncology diseases. The company also offers vaccines for the prevention of various diseases comprising hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia, and others. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is based in Mumbai, India.

5,034 Employees
Last Reported Date: 03/20/14
Founded in 1924

glaxosmithkline pharmaceutic (GLXO) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 26.1M
Executive Director of Technical and Executive...
Total Annual Compensation: 7.0M
Executive Director of Human Resources and Exe...
Total Annual Compensation: 7.2M
Compensation as of Fiscal Year 2013.

glaxosmithkline pharmaceutic (GLXO) Key Developments

GlaxoSmithkline Not Shorlisted Any Buyer

GlaxoSmithkline Pharmaceuticals Limited (BSE:500660) clarified to Bombay Stock Exchange that it has not shortlisted any buyer for its Thane property.

GlaxoSmithKline Pharmaceuticals Limited Announces Change in Financial Year

GlaxoSmithKline Pharmaceuticals Limited has informed that the Board of Directors of the company at its meeting held on November 6, 2014, decided to change the financial year of the company from January - December to April - March. Accordingly the company's current financial year shall be for a period of fifteen months that is from January 1, 2014 to March 31, 2015.

GlaxoSmithkline Pharmaceuticals Limited Announces Executive Changes Effective from December 01, 2014

GlaxoSmithkline Pharmaceuticals Limited appointed Mr. Andrew Aristidou as the Chief Financial Officer and Executive Director of the Company from December 01, 2014. Mehernosh Kapadia, current Chief Financial Officer and Senior Executive Director will retire from service on November 30, 2014 and will cease to be a Director of the Company from December 01, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLXO:IN 2,980.15 INR +104.05

GLXO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GLXO.
View Industry Companies

Industry Analysis


Industry Average

Valuation GLXO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PHARMACEUTIC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at